316 related articles for article (PubMed ID: 10864573)
1. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.
Hanaoka K; Guggino WB
J Am Soc Nephrol; 2000 Jul; 11(7):1179-1187. PubMed ID: 10864573
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea-sensitive K(+) transport is involved in Cl(-) secretion and cyst trowth by cultured ADPKD cells.
Sullivan LP; Wallace DP; Gover T; Welling PA; Yamaguchi T; Maser R; Eppler JW; Grantham JJ
J Am Soc Nephrol; 2002 Nov; 13(11):2619-27. PubMed ID: 12397031
[TBL] [Abstract][Full Text] [Related]
3. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
[TBL] [Abstract][Full Text] [Related]
4. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
[TBL] [Abstract][Full Text] [Related]
5. A role for CFTR in human autosomal dominant polycystic kidney disease.
Hanaoka K; Devuyst O; Schwiebert EM; Wilson PD; Guggino WB
Am J Physiol; 1996 Jan; 270(1 Pt 1):C389-99. PubMed ID: 8772467
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
Li H; Findlay IA; Sheppard DN
Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
8. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro.
Ye M; Grant M; Sharma M; Elzinga L; Swan S; Torres VE; Grantham JJ
J Am Soc Nephrol; 1992 Oct; 3(4):984-94. PubMed ID: 1333294
[TBL] [Abstract][Full Text] [Related]
9. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.
Davidow CJ; Maser RL; Rome LA; Calvet JP; Grantham JJ
Kidney Int; 1996 Jul; 50(1):208-18. PubMed ID: 8807590
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
11. Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
Reif GA; Yamaguchi T; Nivens E; Fujiki H; Pinto CS; Wallace DP
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1005-13. PubMed ID: 21816754
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)].
Miranda N; Miranda F; Rinaldi L; Stratigis S; Capasso G
G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832438
[TBL] [Abstract][Full Text] [Related]
13. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.
Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406
[TBL] [Abstract][Full Text] [Related]
14. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.
Pinto CS; Raman A; Reif GA; Magenheimer BS; White C; Calvet JP; Wallace DP
J Am Soc Nephrol; 2016 Apr; 27(4):1124-34. PubMed ID: 26289612
[TBL] [Abstract][Full Text] [Related]
16. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
Belibi FA; Wallace DP; Yamaguchi T; Christensen M; Reif G; Grantham JJ
J Am Soc Nephrol; 2002 Nov; 13(11):2723-9. PubMed ID: 12397042
[TBL] [Abstract][Full Text] [Related]
17. KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease.
Albaqumi M; Srivastava S; Li Z; Zhdnova O; Wulff H; Itani O; Wallace DP; Skolnik EY
Kidney Int; 2008 Sep; 74(6):740-9. PubMed ID: 18547995
[TBL] [Abstract][Full Text] [Related]
18. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
[TBL] [Abstract][Full Text] [Related]
19. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease.
Terryn S; Ho A; Beauwens R; Devuyst O
Biochim Biophys Acta; 2011 Oct; 1812(10):1314-21. PubMed ID: 21255645
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
Yamaguchi T; Reif GA; Calvet JP; Wallace DP
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
